Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Ganga Pharmaceuticals Ltd. is currently underperforming compared to its peers in terms of growth and profitability, with no revenue or earnings recorded. However, it has a low debt-to-equity ratio, positioning it as a potential deep value pick amid a sector with several strong performers like Sun Pharmaceutical Industries and Cipla, which exhibit robust growth and profitability metrics.
Highest revenue growth YoY at 8.42% and strong profitability with an ROE of 16.13%.
Robust growth with 13.28% revenue growth YoY and very attractive PE ratio of 23.73.
Strong growth trajectory with 18.12% revenue growth YoY and solid profitability metrics.